Analgesics in South Korea

Analgesics in South Korea

The pandemic encouraged many local consumers to limit the number of visits to the doctor in 2020/2021, especially those suffering from minor symptoms. As such, this led to a decline for Rx prescription analgesics, a factor which boosted OTC sales during these years. However, overall retail volume sales of adult analgesics is predicted to decline in 2022, whilst remaining above pre-pandemic levels. Furthermore, the shortage of Rx acetaminophen products was evident in South Korea for more than two...

Euromonitor International's Analgesics in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.